Aptevo Therapeutics Files 8-K Report
Ticker: APVO · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
Related Tickers: APVO
TL;DR
APVO filed an 8-K, but the details are scarce.
AI Summary
On July 1, 2025, Aptevo Therapeutics Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific details regarding material events, acquisitions, or financial changes were provided in the excerpt.
Why It Matters
This filing signals that Aptevo Therapeutics Inc. has made a disclosure to the SEC, but the specific nature of the event is not detailed in the provided text.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediately apparent negative or positive financial or operational implications based on the provided text.
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- July 01, 2025 (date) — Date of earliest event reported
- 206-838-0500 (phone_number) — Registrant's Telephone Number
FAQ
What is the exact nature of the 'Other Events' disclosed in the 8-K filing?
The provided text for the 8-K filing by Aptevo Therapeutics Inc. on July 01, 2025, lists 'Other Events' as the item information but does not specify the details of these events.
When was this 8-K report filed?
The 8-K report was filed as of July 01, 2025, and the date of the earliest event reported is also July 01, 2025.
What is Aptevo Therapeutics Inc.'s principal executive office address?
Aptevo Therapeutics Inc.'s principal executive offices are located at 2401 4th Avenue Suite 1050, Seattle, Washington, 98121.
What is the Commission File Number for Aptevo Therapeutics Inc.?
The Commission File Number for Aptevo Therapeutics Inc. is 001-37746.
Does the filing mention any specific financial transactions or agreements?
The provided excerpt of the 8-K filing does not mention any specific financial transactions or agreements; it only indicates 'Other Events'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Aptevo Therapeutics Inc. (APVO).